Glioma stem cells (GSCs) are the core cause of tumor growth, angiogenesis, and therapeutic resistance in GBM.[61] According to transcriptome data, SOX9, a GSC driving factor, was strongly upregulated. This evidence concerns the gene SOX9 and glioblastoma.